Point72 Asset Management’s Boston Scientific BSX Stock Holding History

Point72 Asset Management’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$231M	Buy	3,687,315 +1,252,752	+51%	+$100M	0.3%	41
2025 Q4	$232M	Buy	2,434,563 +803,510	+49%	+$78.8M	0.26%	44
2025 Q3	$159M	Sell	1,631,053 -829,610	-34%	-$85.9M	0.27%	59
2025 Q2	$264M	Buy	2,460,663 +580,128	+31%	+$58.7M	0.52%	22
2025 Q1	$190M	Sell	1,880,535 -365,264	-16%	-$36.8M	0.43%	40
2024 Q4	$201M	Sell	2,245,799 -1,136,020	-34%	-$100M	0.44%	32
2024 Q3	$283M	Buy	3,381,819 +256,797	+8%	+$20.2M	0.72%	10
2024 Q2	$241M	Buy	3,125,022 +758,833	+32%	+$55.5M	0.63%	11
2024 Q1	$162M	Sell	2,366,189 -2,344,656	-50%	-$151M	0.39%	41
2023 Q4	$272M	Sell	4,710,845 -1,710,909	-27%	-$91.3M	0.66%	8
2023 Q3	$339M	Buy	6,421,754 +2,931,055	+84%	+$154M	0.99%	7
2023 Q2	$189M	Buy	3,490,699 +1,708,999	+96%	+$89.3M	0.56%	19
2023 Q1	$89.1M	Buy	1,781,700 +1,583,831	+800%	+$74.6M	0.28%	79
2022 Q4	$9.16M	Sell	197,869 -2,727,904	-93%	-$118M	0.03%	579
2022 Q3	$113M	Buy	2,925,773 +182,829	+7%	+$7.33M	0.45%	37
2022 Q2	$102M	Buy	2,742,944 +22,144	+0.8%	+$901K	0.43%	40
2022 Q1	$121M	Buy	2,720,800 +817,822	+43%	+$35.4M	0.48%	30
2021 Q4	$80.8M	Buy	1,902,978 +817,400	+75%	+$34.3M	0.32%	63
2021 Q3	$47.1M	Buy	+1,085,578	New	+$48M	0.21%	122
2021 Q1	–	Sell	-95,000	Closed	-$3.42M	–	976
2020 Q4	$3.42M	Buy	95,000 +47,140	+98%	+$1.7M	0.02%	649
2020 Q3	$1.83M	Buy	+47,860	New	+$1.84M	0.01%	717
2020 Q1	–	Sell	-636,554	Closed	-$28.8M	–	792
2019 Q4	$28.8M	Buy	+636,554	New	+$26.6M	0.15%	195
2019 Q3	–	Sell	-48,807	Closed	-$2.1M	–	1152
2019 Q2	$2.1M	Buy	48,807 +38,135	+357%	+$1.47M	0.01%	643
2019 Q1	$410K	Sell	10,672 -137,040	-93%	-$5.23M	﹤0.01%	887
2018 Q4	$5.22M	Sell	147,712 -2,912,215	-95%	-$106M	0.03%	545
2018 Q3	$118M	Buy	3,059,927 +1,590,627	+108%	+$55.6M	0.49%	44
2018 Q2	$48M	Buy	1,469,300 +370,800	+34%	+$11.2M	0.19%	147
2018 Q1	$30M	Buy	+1,098,500	New	+$29.9M	0.13%	207
2017 Q4	–	Sell	-125,500	Closed	-$3.66M	–	912
2017 Q3	$3.66M	Sell	125,500 -922,000	-88%	-$25.5M	0.02%	592
2017 Q2	$29M	Buy	+1,047,500	New	+$27.8M	0.16%	171
2017 Q1	–	Sell	-358,400	Closed	-$7.75M	–	820
2016 Q4	$7.75M	Sell	358,400 -1,264,200	-78%	-$27.6M	0.05%	368
2016 Q3	$38.6M	Sell	1,622,600 -293,382	-15%	-$7M	0.27%	95
2016 Q2	$44.8M	Sell	1,915,982 -749,618	-28%	-$16.2M	0.3%	85
2016 Q1	$50.1M	Buy	2,665,600 +1,975,300	+286%	+$34.7M	0.38%	55
2015 Q4	$12.7M	Sell	690,300 -1,948,000	-74%	-$34.9M	0.11%	227
2015 Q3	$43.3M	Sell	2,638,300 -152,100	-5%	-$2.6M	0.34%	85
2015 Q2	$49.4M	Buy	2,790,400 +1,084,800	+64%	+$19.4M	0.34%	76
2015 Q1	$30.3M	Sell	1,705,600 -2,941,100	-63%	-$46.5M	0.21%	144
2014 Q4	$61.6M	Buy	4,646,700 +2,123,200	+84%	+$27.1M	0.43%	61
2014 Q3	$29.8M	Buy	+2,523,500	New	+$31.8M	0.22%	125

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Point72 Asset Management's BSX Position: Q1 2026 in Review

Point72 Asset Management increased its Boston Scientific (BSX) stake by 51% in Q1 2026, buying an estimated $100M and bringing the position to 3,687,315 shares worth $231M. The position accounts for 0.3% of the portfolio, ranked #41.

Point72 Asset Management first reported a position in BSX in Q3 2014 and has held it in 40 quarters since. The position peaked at $339M in Q3 2023. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

Point72 Asset Management held 3,687,315 shares of Boston Scientific worth $231M as of Q1 2026.
Point72 Asset Management bought 1,252,752 Boston Scientific shares in Q1 2026, an estimated $100M.
Boston Scientific made up 0.3% of Point72 Asset Management's portfolio in Q1 2026, its #41 holding.
Point72 Asset Management first reported a position in Boston Scientific in Q3 2014 and has held it in 40 quarters since.
Point72 Asset Management's Boston Scientific position peaked at $339M in Q3 2023.
1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Point72 Asset Management's 13F filing for Q1 2026, filed 15 May 2026.